🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

The ABEVA is pleased to inform you that the film "Breathless" will be shown at the iMig Conference 2023, in room 2.3 at the Grand Palais in Lille, from 6pm to 6:50pm imig2023.org/program/ #ABEVA #Mesothelioma #Research #Oncology #Cancer #OncoFR #France IFCT lung EMERGENCE PCO

Opening of the 3-day conference iMig2023: more than 500 participants in Lille Grand Palais from all over the world. #IMIG2023 #mesothelioma #clinicaltrials #research #asbestos Welcome speech by Scherpereel Arnaud

Thank you to the team CHU de Lille for hosting iMig2023 nursing workshop ITONF visit yesterday. Your warmth and kindness were so appreciated.

Day 1 workshop "Focussing on patients experience : improving mesothelioma patients and relatives management" iMig2023 IFCT lung #mesothelioma Nick maskell Daniel Sterman Linda Reinstein @rintoul_robert

We are really pleased to be in Lille supporting #imig2023 Beautiful city and a great conference to hear about the exciting medical advances in #mesothelioma treatment

Dr Kevin Lamote presenting his work on non-invasive biomarkers for mesothelioma at iMig2023 Kevin's work is a key part of the PREDICT-Meso #MesoORIGINS study and could aid in how #mesothelioma is detected using exhaled breath #imig2023 #MesotheliomaResearch #EarlyDetection

Professor Anna Nowak (Anna Nowak) reflecting on how the iMig Young Investigator Award, which she received in 2002, shaped her inspiring, successful career serving the mesothelioma research and patient communities iMig2023 #IMIG2023

Also representing NCARD this morning is Dr Kofi Stevens, talking about his work that utilises targeted epigenetic editing to enhance the immune response to mesothelioma iMig2023 #IMIG2023

It was wonderful to be able to reflect on the role of multidisciplinary science, #collaboration, #teamwork, and #mentorship and how important these are for iMig2023 and the #RareCancer #mesothelioma

Surgery, Radiotherapy, (neo)adjuvant therapies: what is the best combo for multimodal treatment ? #mesothelioma Dr. Marc de Perrot & Scherpereel Arnaud iMig2023 IFCT lung #iMig2023

IFCT & iMig Presidents reflecting on keynote speakers, panelists, best submitted abstracts and networking opportunities which will help to establish research collaboration for mesothelioma research IFCT lung iMig2023 #mesothelioma #iMig2023 #cancer

Great overview of BAP1 germline mesothelioma by Michele Carbone, pioneer in the field. A medical and genetic story with human and social impact. iMig2023

Encore presentation of the phase III IND227 IFCT1901 trial by Scherpereel Arnaud iMig2023 : better ORR and OS in chemo + pembro arm vs chemo alone in mesothelioma. Impact of histology, no impact of PDL1.

Congratulations to the 3 young investigators award winners : Matthieu Foll (France), Kofi Stevens (Australia), Michelle Dietz (Netherlands) & the three seniors award winners : Dean Fennell (UK), Mary Hesdorffer (USA), Hedy Kindler (USA) #mesothelioma #research IFCT lung #iMig2023

🔹IMIG 2023 - mediscoop.net🔹 Suivez les comptes rendus vidéos à l’occasion du congrès de l’international Mesothelioma Interest Group 2023 sur cancero.net Bon visionnage #IMIG2023 👉🏻 bit.ly/3XxGYmX 👈🏻

Félicitations aux 13 membres du Conseil d'admin. de l'IFCT élus pour 2 ans lors de l'Assemblée générale du 23/06. Merci aux membres sortants pour leur implication : A. Cortot CHU de Lille, P. Fournel CHU de Saint-Étienne, A. Seguin-Givelet IM MONTSOURIS : ifct.fr/a-propos-de-l-…

Retrouvez le compte rendu de la conférence #iMiG2023 en format vidéos d’experts ! lecancer.fr/congres/imig-2… Scherpereel Arnaud Blanquart Christophe Diane Damotte Anna Nowak Didier JEAN Gerard ZALCMAN & V. Westeel, S. Lantuejoul, M. de Perrot, E. Jonckheer #research #mesothelioma LeCancer.fr

A l'occasion de Novembre Perle #LungCancerAwarenessMonth , l’IFCT tient à saluer l'engagement commun des associations dans leur rôle d’information et de sensibilisation des patients à la recherche clinique dont Mon Réseau Cancer du Poumon alk ros1 france cancer poumon La Ligue contre le cancer

Last IFCT article now online in Lancet Oncol, Aug. 9th: how to optimize thoracic RT in stage3 NSCLC with interim 42Gy FDG-PET CT: Phase2R RTEP7 -IFCT1402 ⁦IFCT lung⁩ ⁦Gerard ZALCMAN⁩ ⁦Philippe Giraud⁩ 🙏Prof. Pierre Vera & Sébastien Thureau

Workshop #mesotheliome pleural : les nouveaux essais cliniques IFCT BI-MAPS (ivonescimab, 38 pts) et LAG-MAPS (cemiplimab+fianlimab+CT, 126 pts) présentés et bientôt disponibles dans 40 centres en France. Des innovations pour le plus grand nombre. Hôpital Cochin-Port-Royal AP-HP